biblio
“Rivaroxaban eutectics with improved solubility, dissolution rates, bioavailability and stability”, Crystengcomm, vol. 25, no. 22, pp. 3253-3263, 2023.
, “Polymorphs and hydrates of the anticancer drug erlotinib: X-ray crystallography, phase transition and biopharmaceutical studies”, CrystEngComm, vol. 23, no. 22, pp. 3961-3974, 2021.
, “Drug-drug cocrystals of anticancer drugs erlotinib-furosemide and gefitinib-mefenamic acid for alternative multi-drug treatment”, Crystengcomm, vol. 22, no. 37, pp. 6137-6151, 2020.
,